Barinthus Biotherapeutics UK Ltd

Barinthus Biotherapeutics (UK) Limited operates as a clinical-stage biopharmaceutical company. The Company focuses on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. Barinthus Biotherapeutics (UK) serves customers in the United Kingdom and in the United States.